Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Retinal Detachment D012163 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Influenza, Human D007251 11 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Lung Injury D055370 14 associated lipids
Thrombocytopenia D013921 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Endotoxemia D019446 27 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Nguyen-Tran DH et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. 2014 Dis Model Mech pmid:24077965
Tanaka K et al. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model. 2014 Clin. Exp. Immunol. pmid:24028747
Kihara A Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids. 2014 Biochim. Biophys. Acta pmid:23994042
Waeber C and Walther T Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction. 2014 Circ. J. pmid:24632793
Brünnert D et al. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells. 2014 Mol. Hum. Reprod. pmid:24994816
Nagamatsu T et al. Emerging roles for lysophospholipid mediators in pregnancy. 2014 Am. J. Reprod. Immunol. pmid:24689547
Xu M et al. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway. 2014 Acta Pharmacol. Sin. pmid:25399649
Watanabe C et al. Antagonism and synergy of single chain sphingolipids sphingosine and sphingosine-1-phosphate toward lipid bilayer properties. Consequences for their role as cell fate regulators. 2014 Langmuir pmid:25386673
Plano D et al. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. 2014 J. Med. Chem. pmid:24471412
Nakamura H and Murayama T Role of sphingolipids in arachidonic acid metabolism. 2014 J. Pharmacol. Sci. pmid:24599139
Guo S et al. Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen. 2014 Biochim. Biophys. Acta pmid:24603322
Kempf A et al. The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. 2014 PLoS Biol. pmid:24453941
Sutter I et al. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. 2014 J. Lipid Res. pmid:24950692
Yang W et al. Sphingosine-1-phosphate promotes extravillous trophoblast cell invasion by activating MEK/ERK/MMP-2 signaling pathways via S1P/S1PR1 axis activation. 2014 PLoS ONE pmid:25188412
Chen J et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. 2014 Am. J. Respir. Crit. Care Med. pmid:25180446
Rauch BH Sphingosine 1-phosphate as a link between blood coagulation and inflammation. 2014 Cell. Physiol. Biochem. pmid:24977491
Mahajan-Thakur S et al. Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. 2014 J. Leukoc. Biol. pmid:24990321
Kondo S et al. Memo has a novel role in S1P signaling and is [corrected] crucial for vascular development. 2014 PLoS ONE pmid:24714781
Korbelik M et al. Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. 2014 Int. Immunopharmacol. pmid:24713544
Gatfield J et al. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling. 2014 Cell. Signal. pmid:24704119
Mendes-Braz M et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. 2014 Liver Int. pmid:24107124
Baranowski M et al. Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration. 2014 Int J Sport Nutr Exerc Metab pmid:24092763
Lee H et al. 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. 2013 May-Jun Islets pmid:23756681
Egom EE et al. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. 2013 May-Jun Crit Rev Clin Lab Sci pmid:23885725
Ratajczak MZ et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22981511
Morozov VI et al. Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. 2013 Jan-Feb Ukr Biokhim Zh (1999) pmid:23534286
Price MM et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. 2013 J. Allergy Clin. Immunol. pmid:22939756
Kimizuka K et al. Sphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels. 2013 Microcirculation pmid:22913344
Herzog BH et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. 2013 Nature pmid:23995678
Kotani T et al. Altered expression of enzymes regulating the activity of endothelin-1 in the lower segment of the human amnion during labor. 2013 Biol. Reprod. pmid:23863409
Zhao CG et al. Sphingosine-1-phosphate is a possible fibrogenic factor in gluteal muscle fibrosis. 2013 Physiol Res pmid:23869887
Knapp M et al. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction. 2013 Prostaglandins Other Lipid Mediat. pmid:24120760
Yuan S et al. Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations. 2013 PLoS Comput. Biol. pmid:24098103
Gaveglio VL et al. Phosphatidic acid metabolism in rat liver cell nuclei. 2013 FEBS Lett. pmid:23439070
Wirotanseng LN et al. Gq rather than G11 preferentially mediates nociceptor sensitization. 2013 Mol Pain pmid:24156378
Kurek K et al. [The role of sphingolipids in selected cardiovascular diseases]. 2013 Postepy Hig Med Dosw (Online) pmid:24088546
Kowalski GM et al. Plasma sphingosine-1-phosphate is elevated in obesity. 2013 PLoS ONE pmid:24039766
Ohotski J et al. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. 2013 Int. J. Cancer pmid:22733311
Chan H and Pitson SM Post-translational regulation of sphingosine kinases. 2013 Biochim. Biophys. Acta pmid:22801036
Deng H et al. Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. 2013 ACS Med Chem Lett pmid:24900589
Zhang W et al. Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells. 2013 Prostaglandins Other Lipid Mediat. pmid:23770055
Selhub J et al. Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease. 2013 J. Nutr. Biochem. pmid:24183308
Ishii M and Kikuta J Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. 2013 Biochim. Biophys. Acta pmid:22691949
Ley S et al. The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages. 2013 Oncogene pmid:22410777
Dziak R The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. 2013 Immunol. Invest. pmid:24004055
Schwalm S et al. Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22889995
Zhang O et al. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence. 2013 Mol. Microbiol. pmid:23980754
Tran-Dinh A et al. HDL and endothelial protection. 2013 Br. J. Pharmacol. pmid:23488589
Mudd JC et al. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. 2013 Blood pmid:23422746
Olivera A et al. Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression. 2013 J. Leukoc. Biol. pmid:23904439
Sun X et al. Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. 2013 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23911438
Hardin C et al. Glassy dynamics, cell mechanics, and endothelial permeability. 2013 J Phys Chem B pmid:23638866
Xiang SY et al. PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart. 2013 Sci Signal pmid:24345679
Salmanzadeh A et al. Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model. 2013 Integr Biol (Camb) pmid:23609351
Orr Gandy KA et al. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation. 2013 FASEB J. pmid:23629860
Schneider G et al. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. 2013 Mol. Cancer Res. pmid:23615526
Goyal P et al. Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways. 2013 Mol. Hum. Reprod. pmid:23538947
Cinq-Frais C et al. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1. 2013 Biochim. Biophys. Acta pmid:23651497
Christoffersen C and Nielsen LB Apolipoprotein M: bridging HDL and endothelial function. 2013 Curr. Opin. Lipidol. pmid:23652568
Egom EE et al. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. 2013 Curr. Opin. Lipidol. pmid:23652570
Lundblad C et al. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. 2013 Acta Anaesthesiol Scand pmid:23683126
Kroetsch JT and Bolz SS The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure. 2013 J. Vasc. Res. pmid:23594703
Allende ML et al. Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. 2013 J. Biol. Chem. pmid:23637227
Schaper K et al. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. 2013 J. Dermatol. Sci. pmid:23643308
Böhm A et al. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. 2013 Cardiovasc. Res. pmid:23658376
Kurano M et al. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. 2013 Atherosclerosis pmid:23664237
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Lee YJ et al. Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling. 2013 Int. J. Mol. Med. pmid:23381659
Yangyuoru PM et al. Fluorescent lipids as probes for sphingosine kinase activity by capillary electrophoresis. 2013 Methods Mol. Biol. pmid:23386355
Dillahunt SE et al. Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined. 2013 J. Immunol. pmid:23359503
Tong X et al. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. 2013 Cardiovasc Diabetol pmid:23360427
Finley A et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. 2013 PLoS ONE pmid:23372844
Dusaban SS et al. Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23401561
Del Galdo S et al. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis. 2013 Cell. Signal. pmid:23993968
Kalhori V et al. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells. 2013 PLoS ONE pmid:23824493
Guo H et al. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. 2013 J. Neurosci. pmid:23554499
Carr JM et al. Sphingosine kinase 1 in viral infections. 2013 Rev. Med. Virol. pmid:22639116
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Zu Heringdorf DM et al. Pharmacology of the sphingosine-1-phosphate signalling system. 2013 Handb Exp Pharmacol pmid:23579459
Matheu MP et al. Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy. 2013 PLoS ONE pmid:23533579
Sobel K et al. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. 2013 J. Biol. Chem. pmid:23589284
Barth BM et al. Gaucher's disease and cancer: a sphingolipid perspective. 2013 Crit Rev Oncog pmid:23510065
Bernhart E et al. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. 2013 Exp. Cell Res. pmid:23562655
Selvam SP and Ogretmen B Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. 2013 Handb Exp Pharmacol pmid:23563649
Pyne S and Pyne NJ New perspectives on the role of sphingosine 1-phosphate in cancer. 2013 Handb Exp Pharmacol pmid:23563651
Jiang XC and Liu J Sphingolipid metabolism and atherosclerosis. 2013 Handb Exp Pharmacol pmid:23563655
Levkau B Cardiovascular effects of sphingosine-1-phosphate (S1P). 2013 Handb Exp Pharmacol pmid:23563656
Abbasi T and Garcia JG Sphingolipids in lung endothelial biology and regulation of vascular integrity. 2013 Handb Exp Pharmacol pmid:23563658
Gandy KA and Obeid LM Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway. 2013 Handb Exp Pharmacol pmid:23563662
Park K et al. Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production. 2013 J. Invest. Dermatol. pmid:23856934
Huang LS et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. 2013 FASEB J. pmid:23315259
Lukowski ZL et al. Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. 2013 J. Glaucoma pmid:21946553
Heffernan-Stroud LA and Obeid LM Sphingosine kinase 1 in cancer. 2013 Adv. Cancer Res. pmid:23290781
Zhang J et al. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration. 2013 Hum. Reprod. pmid:24001716
Kihara A [Complete metabolic pathway of sphingosine 1-phosphate and its importance as a metabolic intermediate]. 2013 Seikagaku pmid:23980469
Weichand B et al. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. 2013 Eur. J. Immunol. pmid:23934754
Morad SA et al. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells. 2013 Biochim. Biophys. Acta pmid:23939396
Banitalebi E et al. The effect of resistance training on plasma S1P level and gene expression of S1P1,2,3 receptors in male Wistar rats. 2013 Minerva Endocrinol. pmid:24285107
Rokka J et al. 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical. 2013 J Labelled Comp Radiopharm pmid:24285478
Kajimoto T et al. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. 2013 Nat Commun pmid:24231649